ClassID:

94731

C07D273/00 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups  - 

Sub-classes:
Recent Application in this class:
#1
20260041771
2026-02-12

NOVEL HYDRAZONE-BASED VISIBLE LIGHT-ACTIVATED NITROXYL AND NITROUS OXIDE DONORS

#2
20250236637
2025-07-24

GUANINE-RICH OLIGONUCLEOTIDES

#3
20240400525
2024-12-05

1,2,4-Oxadiazole Derivatives as Immunomodulators

#4
20230416296
2023-12-28

GUANINE-RICH OLIGONUCLEOTIDES

#5
20230270892
2023-08-31

CHELATOR COMPOSITIONS FOR RADIOMETALS AND METHODS OF USING SAME

#6
20230167076
2023-06-01

1,2,4-oxadiazole derivatives as immunomodulators

#7
20230151034
2023-05-18

PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION

#8
20230094587
2023-03-30

Simplified structural mimetics of AIPS as quorum sensing inhibitors

#9
20230020952
2023-01-19

MACROCYCLES COMPRISING A 4-AMIDO-2,4-PENTADIENOATE MOIETY FOR THE TREATMENT OF HYPOXIC CANCERS

#10
20220401856
2022-12-22

Chromatographic separation of metals using DOTA-based chelators

#11
20220382156
2022-12-01

Extreme ultraviolet photoresist with high-efficiency electron transfer

#12
20220323540
2022-10-13

Endoparasitic depsipeptides

#13
20220098241
2022-03-31

Anthelmintic depsipeptide compounds

#14
20210260195
2021-08-26

CONJUGATED LIPOMERS AND USES THEREOF

#15
20210198219
2021-07-01

1,2,4-oxadiazole derivatives as immunomodulators

#16
20210179606
2021-06-17

Compositions comprising macrocycle derivatives incorporating bridged macrocycles and methods of producing and using same

#17
20210024476
2021-01-28

Simplified structural mimetics of AIPS as quorum sensing inhibitors

#18
20200386763
2020-12-10

Conjugated oligomer-based macrocycles for live cell imaging

#19
20200354408
2020-11-12

Anthelmintic depsipeptide compounds

#20
20200199086
2020-06-25

1,2,4-oxadiazole derivatives as immunomodulators

#21
20200124964
2020-04-23

Extreme ultraviolet photoresist with high-efficiency electron transfer

#22
20190307838
2019-10-10

Anthelmintic depsipeptide compounds

#23
20190276741
2019-09-12

Reactive mesogen and liquid crystal composition including the same

#24
20190248840
2019-08-15

Anthelmintic depsipeptide compounds

#25
20190167795
2019-06-06

Conjugated lipomers and uses thereof

#26
20190144402
2019-05-16

1,2,4-oxadiazole derivatives as immunomodulators

#27
20180362589
2018-12-20

Anthelmintic depsipeptide compounds

#28
20180251459
2018-09-06

Compositions comprising macrocycle derivatives incorporating bridged macrocycles and methods of producing and using same

#29
20180228768
2018-08-16

Macrocyclic ghrelin receptor modulators and methods of using the same

#30
20180194795
2018-07-12

GUANINE-RICH OLIGONUCLEOTIDES

#31
20180173101
2018-06-21

Extreme ultraviolet photoresist with high-efficiency electron transfer

#32
20180170889
2018-06-21

Simplified structural mimetics of AIPS as quorum sensing inhibitors

#33
20180072689
2018-03-15

1,2,4-oxadiazole derivatives as immunomodulators

#34
20180044350
2018-02-15

THERAPEUTIC CYCLIC COMPOUNDS AS IMMUNOMODULATORS

#35
20180023000
2018-01-25

Reactive mesogen and liquid crystal composition including the same

#36
20170338417
2017-11-23

Compound having substituted triphenylene ring structure, and organic electroluminescent device

#37
20170271595
2017-09-21

Compound having substituted triphenylene ring structure, and organic electroluminescent device

#38
20170233438
2017-08-17

Anthelmintic depsipeptide compounds

#39
20170215422
2017-08-03

NOVEL CYCLIC DEPSIPEPTIDE DERIVATIVES AND HARMFUL ORGANISM CONTROL AGENTS COMPRISING THE SAME

#40
20170042858
2017-02-16

Macrocyclic ghrelin receptor modulators and methods of using the same

#41
20170022253
2017-01-26

Anthelmintic depsipeptide compounds

#42
20160237047
2016-08-18

Process for preparing fluoxastrobin

#43
20160221971
2016-08-04

Di-macrocycles

#44
20160221927
2016-08-04

Intermediates for macrocyclic compounds

#45
20160206740
2016-07-21

Conjugated lipomers and uses thereof

#46
20160137617
2016-05-19

Macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors

#47
20150284404
2015-10-08

Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors

#48
20150240006
2015-08-27

Solid-phase supports and uses thereof

#49
20150183831
2015-07-02

Method for producing cereulide and derivative thereof, intermediate for production of cereulide, and cereulide derivative

#50
20150148290
2015-05-28

Macrocyclic modulators of the ghrelin receptor

#51
20150105354
2015-04-16

Heterocyclic aspartyl protease inhibitors

#52
20150073042
2015-03-12

Cyclic peptidomimetic compounds as immunomodulators

#53
20150011753
2015-01-08

Process for preparing fluoxastrobin

#54
20150005319
2015-01-01

Macrocyclic compounds for modulating IL-17

#55
20140299822
2014-10-09

Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative

#56
20140187527
2014-07-03

Macrocyclic compounds and metal complexes for bioimaging and biomedical applications

#57
20140057910
2014-02-27

Heterocyclic aspartyl protease inhibitors

#58
20140034936
2014-02-06

Compound having substituted triphenylene ring structure, and organic electroluminescent device

#59
20130211045
2013-08-15

Macrocyclic modulators of the Ghrelin receptor

#60
20130081999
2013-04-04

Bridged Macrocyclic Module Compositions

#61
20130053530
2013-02-28

Method for preparing a poly(ether sulfonimide or -amide) copolymer using cyclic oligomers

#62
20130018066
2013-01-17

Heterocyclic aspartyl protease inhibitors

#63
20120302496
2012-11-29

NOVEL 24-MEMBERED CYCLOOCTADEPSIPEPTIDES FROM FUNGAL STRAINS AND THEIR USE AS ANTHELMINTICS OR ENDOPARASITICIDES

#64
20120296085
2012-11-22

CHEMILUMINESCENT DYES AND DYE-STAINED PARTICLES

#65
20120276001
2012-11-01

Bifunctional polyazamacrocyclic chelating agents

#66
20120251560
2012-10-04

Conjugated lipomers and uses thereof

#67
20120232268
2012-09-13

Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof

#68
20120226072
2012-09-06

PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS

#69
20120226067
2012-09-06

PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS

#70
20120226066
2012-09-06

PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS

#71
20120165566
2012-06-28

PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS

#72
20120058891
2012-03-08

Oxadiazine-substituted arylamides

#73
20120022053
2012-01-26

Oxadiazine Derivatives

#74
20110245459
2011-10-06

Processes for intermediates for macrocyclic compounds

#75
20110245159
2011-10-06

Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same

#76
20110218194
2011-09-08

Heterocyclic aspartyl protease inhibitors

#77
20110065710
2011-03-17

Insecticidal N-(heteroarylalkyl)alkanediamine derivatives

#78
20100290951
2010-11-18

Surface-based ammonium ion sensor and methods of making thereof

#79
20100256049
2010-10-07

Macrolactone derivatives

#80
20100197676
2010-08-05

5-substituted-2-phenylamino benzamides as MEK inhibitors

#81
20100152099
2010-06-17

Macrocyclic compounds for inhibition of tumor necrosis factor alpha

#82
20100113770
2010-05-06

O-SUBSTITUTED HYDROXYARYL DERIVATIVES

#83
20100093720
2010-04-15

Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders

#84
20100047821
2010-02-25

Crown ether derivatives

#85
20100036122
2010-02-11

CLEAVAGE AGENT SELECTIVELY ACTING ON SOLUBLE ASSEMBLY OF AMYLOIDOGENIC PEPTIDE OR PROTEIN

#86
20100022500
2010-01-28

Macrocyclic Lactams and Pharmaceutical Use Thereof

#87
20090312370
2009-12-17

MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS

#88
20090306047
2009-12-10

Heterocyclic aspartyl protease inhibitors

#89
20090275648
2009-11-05

MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME

#90
20090264315
2009-10-22

DIPEPTIDE MIMICS, LIBRARIES COMBINING TWO DIPEPTIDE MIMICS WITH A THIRD GROUP, AND METHODS FOR PRODUCTION THEREOF

#91
20090258868
2009-10-15

Heterocyclic aspartyl protease inhibitors

#92
20090240027
2009-09-24

Intermediates for macrocyclic compounds

#93
20090233915
2009-09-17

5-Substituted-2-phenylamino benzamides as MEK inhibitors

#94
20090221697
2009-09-03

MACROLIDE CONJUGATES OF PYRROLIZINE AND INDOLIZINE COMPOUNDS AS INHIBITORS OF 5-LIPOOXYGENASE AND CYCLOOXYGENASE

#95
20090221689
2009-09-03

Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor

#96
20090202521
2009-08-13

Bifunctional polyazamacrocyclic chelating agents

#97
20090180985
2009-07-16

Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors

#98
20090143228
2009-06-04

Dioxazine-substituted arylamides

#99
20090137835
2009-05-28

Processes for intermediates for macrocyclic compounds

#100
20090111958
2009-04-30

Catalyst systems based on macrocyclic ligands

#101
20090029960
2009-01-29

Macrocyclic compounds useful as BACE inhibitors

#102
20080306041
2008-12-11

Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use

#103
20080290034
2008-11-27

Bridged macrocyclic module compositions

#104
20080287407
2008-11-20

Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use

#105
20080194691
2008-08-14

Macrocyclic inhibitors of BCL proteins

#106
20080194672
2008-08-14

Macrocyclic ghrelin receptor modulators and methods of using the same

#107
20080167444
2008-07-10

Abc Transporter Inhibitor

#108
20080139523
2008-06-12

Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors

#109
20080132477
2008-06-05

Macrocyclic Compounds Useful as Bace Inhibitors

#110
20080103135
2008-05-01

Phenylalkynes

#111
20080096876
2008-04-24

Phenylalkynes

#112
20080026990
2008-01-31

18-membered nitrobenzyl- and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites and a process for their preparation

#113
20070219188
2007-09-20

Oxadiazine derivatives

#114
20070155748
2007-07-05

N-sulfonyl-α-amino-acid derivatives

#115
20070149784
2007-06-28

Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative

#116
20070072852
2007-03-29

Heterocyclic aspartyl protease inhibitors

#117
20070072837
2007-03-29

Phenylalkynes

#118
20070072792
2007-03-29

Macrocyclic lactams and pharmaceutical use thereof

#119
20070066851
2007-03-22

Palladium-catalyzed carbon-carbon bond forming reactions

#120
20070043212
2007-02-22

Crown ether derivatives

#121
20070021406
2007-01-25

Neurokinin antagonists for use as medicaments

#122
20060258859
2006-11-16

Phenylalkynes

#123
20060252930
2006-11-09

Fki-1366 substances and process for producing the same

#124
20060111370
2006-05-25

Heterocyclic aspartyl protease inhibitors

#125
20060094718
2006-05-04

O-substituted hydroxyaryl derivatives

#126
20060069047
2006-03-30

Antibiotic conjugates

#127
20060035884
2006-02-16

N-cyclic sulfonamido inhibitors of gamma secretase

#128
20060030553
2006-02-09

Cell adhesion inhibitors

#129
20060025566
2006-02-02

Macrocyclic modulators of the ghrelin receptor

#130
20050250822
2005-11-10

Substituted benzanilide compound and noxious organism controlling agent

#131
20050215587
2005-09-29

Serine protease inhibitors

#132
20050154199
2005-07-14

Bridged macrocyclic module compositions

#133
20050124506
2005-06-09

Lubricating oil composition for automatic transmissions

#134
20050080003
2005-04-14

Compounds with anti-inflammatory activity

#135
20050054633
2005-03-10

Malonamide derivatives

#136
20050054562
2005-03-10

Macrocyclic antagonists of the motilin receptor